118 related articles for article (PubMed ID: 2171581)
1. The effects of capsular polysaccharide on the capacity of serum to support the killing of type 3 Streptococcus pneumoniae by human neutrophils.
Esposito AL; Clark CA
APMIS; 1990 Sep; 98(9):812-22. PubMed ID: 2171581
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
Schweinle JE
Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro.
Esposito AL; Clark CA; Poirier WJ
APMIS; 1990 Feb; 98(2):111-21. PubMed ID: 2405890
[TBL] [Abstract][Full Text] [Related]
4. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
Giebink GS; Grebner JV; Kim Y; Quie PG
Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
[TBL] [Abstract][Full Text] [Related]
5. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
Connolly JC; McLean C; Tabaqchali S
J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
[TBL] [Abstract][Full Text] [Related]
6. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae.
Vitharsson G; Jónsdóttir I; Jónsson S; Valdimarsson H
J Infect Dis; 1994 Sep; 170(3):592-9. PubMed ID: 8077716
[TBL] [Abstract][Full Text] [Related]
7. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.
Janoff EN; Fasching C; Orenstein JM; Rubins JB; Opstad NL; Dalmasso AP
J Clin Invest; 1999 Oct; 104(8):1139-47. PubMed ID: 10525053
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration.
Gómez-Lus ML; Giménez MJ; Prieto J; Martín M; Frías J; Aguilar L
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):40-3. PubMed ID: 9512181
[TBL] [Abstract][Full Text] [Related]
9. Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.
Dhingra RK; Williams RC; Reed WP
Infect Immun; 1977 Jan; 15(1):169-74. PubMed ID: 13039
[TBL] [Abstract][Full Text] [Related]
10. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.
Simell B; Vuorela A; Ekström N; Palmu A; Reunanen A; Meri S; Käyhty H; Väkeväinen M
Vaccine; 2011 Feb; 29(10):1929-34. PubMed ID: 21236231
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
Braconier JH; Odeberg H; Sjöholm AG
Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
[TBL] [Abstract][Full Text] [Related]
12. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
13. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
[TBL] [Abstract][Full Text] [Related]
14. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
[TBL] [Abstract][Full Text] [Related]
15. Antibody-Mediated Killing of Carbapenem-Resistant ST258
Kobayashi SD; Porter AR; Freedman B; Pandey R; Chen L; Kreiswirth BN; DeLeo FR
mBio; 2018 Mar; 9(2):. PubMed ID: 29535199
[TBL] [Abstract][Full Text] [Related]
16. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
[TBL] [Abstract][Full Text] [Related]
17. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F.
Lucas AH; Granoff DM; Mandrell RE; Connolly CC; Shan AS; Powers DC
Infect Immun; 1997 Dec; 65(12):5103-9. PubMed ID: 9393802
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
Bjornson AB; Lobel JS
J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
[TBL] [Abstract][Full Text] [Related]
19. Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae.
Akahori Y; Miyasaka T; Toyama M; Matsumoto I; Miyahara A; Zong T; Ishii K; Kinjo Y; Miyazaki Y; Saijo S; Iwakura Y; Kawakami K
BMC Immunol; 2016 Jan; 17():1. PubMed ID: 26727976
[TBL] [Abstract][Full Text] [Related]
20. Agglutination and phagocytosis of pneumococci by immunoglobulin G antibodies of restricted heterogeneity.
Reed WP; Stromquist DL; Williams RC
J Lab Clin Med; 1983 Jun; 101(6):847-56. PubMed ID: 6854124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
